Strategic Partnerships Independent nonprofit CRO with a nationwide network of over 450 academic and community sites presents affinity for collaboration with academia, pharma, and biotech—a strong platform for co-development, multi-site trials, and investigator-initiated studies.

Early Phase Focus Specializes in early phase multi-center oncology clinical trials, offering end-to-end study management including design, regulatory and IND support, safety reporting, and data management—appealing to sponsors seeking rapid feasibility and execution for first-in-human or dose-escalation studies.

Operational Capabilities Comprehensive service stack (budgeting, contracting, LOI, EDC development, monitoring, correlative management, and publication support) enables sponsors to streamline trial operations and shorten cycle times across diverse sites.

Leadership Stability Recent leadership appointment of a new CEO and prior industry recognition (Sustained Excellence Award) signal strategic focus, governance maturity, and potential for growth in project throughput and enterprise collaborations.

Scale and Market Position Revenue in the mid-range for CRO peers with a mid-sized employee base and broad site network; positioned among similarly funded oncology CROs, offering a balance of agility and reach attractive to sponsors needing breadth without top-tier vendor scale.